摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-溴苯)乙胺盐酸盐 | 39260-89-4

中文名称
2-(4-溴苯)乙胺盐酸盐
中文别名
2-(4-溴苯)乙胺盐酸盐,97;4-溴苯乙胺盐酸盐;2-(4-溴苯基)乙胺盐酸盐
英文名称
2-(4-bromophenyl)ethan-1-amine hydrochloride
英文别名
2-(4-Bromophenyl)ethylazanium;chloride
2-(4-溴苯)乙胺盐酸盐化学式
CAS
39260-89-4
化学式
C8H10BrN*ClH
mdl
——
分子量
236.539
InChiKey
ZHAWIPAHUYMLDV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    240-243 °C

计算性质

  • 辛醇/水分配系数(LogP):
    2.37
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    26
  • 氢给体数:
    2
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2921499090

SDS

SDS:3fde096709956df03da9639ff1d0dee3
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Bromophenylethanamine, HCl
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromophenylethanamine, HCl
CAS number: 39260-89-4

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H11BrClN
Molecular weight: 236.5

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    2-(4-溴苯)乙胺盐酸盐盐酸 作用下, 以 四氢呋喃 为溶剂, 反应 6.0h, 生成 1-[2-(4-溴-苯基)-乙基]-咪唑烷-2,4,5-三酮
    参考文献:
    名称:
    Highly Selective Aldose Reductase Inhibitors. 1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic Acids
    摘要:
    A series of 3-(arylalkyl)-2,4,5-trioxoimidazolidine-1-acids (1) was prepared and tested for aldose reductase (AR) and aldehyde reductase (ALR) inhibitory activities. These compounds showed strong inhibitory activity against AR without significant inhibitory activity for ALR. The ratio of IC50(ALR)/IC50(AR) was > 1000 in some compouds. On the basis of pharmacological tests such as the recovery of reduced motor nerve conduction velocity and toxicological profile, 3-(3-nitrobenzyl)-2,4,5-trioxoimidazolidine-1-acid (NZ-314) was selected as the candidate for clinical development.
    DOI:
    10.1021/jm9508393
  • 作为产物:
    描述:
    反-4-溴-β-硝基苯乙烯 在 lithium aluminium tetrahydride 、 盐酸 作用下, 以 四氢呋喃乙酸乙酯 为溶剂, 反应 2.0h, 以23%的产率得到2-(4-溴苯)乙胺盐酸盐
    参考文献:
    名称:
    HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF
    摘要:
    本文提供了融合咪唑基化合物,其合成方法以及使用方法。本文提供的化合物对于治疗、预防和/或管理各种疾病,如神经系统疾病和代谢性疾病,具有用处。本文提供的化合物抑制组胺H3受体的活性,并调节各种神经递质的释放,如组胺、乙酰胆碱、去甲肾上腺素和多巴胺(例如在突触处)。本文还提供了含有这些化合物的药物配方及其使用方法。
    公开号:
    US20100204214A1
点击查看最新优质反应信息

文献信息

  • Phosphine-Free Manganese Catalyst Enables Selective Transfer Hydrogenation of Nitriles to Primary and Secondary Amines Using Ammonia–Borane
    作者:Koushik Sarkar、Kuhali Das、Abhishek Kundu、Debashis Adhikari、Biplab Maji
    DOI:10.1021/acscatal.0c05406
    日期:2021.3.5
    primary and secondary amines by nitrile hydrogenation, employing a borrowing hydrogenation strategy. A class of phosphine-free manganese(I) complexes bearing sulfur side arms catalyzed the reaction under mild reaction conditions, where ammonia–borane is used as the source of hydrogen. The synthetic protocol is chemodivergent, as the final product is either primary or secondary amine, which can be controlled
    在本文中,我们报告了采用借位氢化策略通过腈加氢合成伯胺和仲胺的方法。一类带有硫侧臂的无膦锰(I)络合物在温和的反应条件下催化反应,其中氨硼烷用作氢源。合成规程是化学发散的,因为最终产物是伯胺或仲胺,可以通过改变催化剂结构和反应介质的极性来控制。该方法的显着优点是该方案无需外部添加碱或其他添加剂即可运行,并且避免了其他腈加氢反应所需的高压二氢气体的使用。利用这种方法 以高收率合成了各种各样的伯胺,对称胺和不对称仲胺。涉及动力学实验和高水平DFT计算的机理研究表明,外球面脱氢和内球面加氢在催化循环中均主要起作用。
  • [EN] TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS DE TRIAZOLOTRIAZINE EN TANT QU'ANTAGONISTES DU RÉCEPTEUR A2A
    申请人:ZHEJIANG VIMGREEN PHARMACEUTICALS LTD
    公开号:WO2020002968A1
    公开(公告)日:2020-01-02
    The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyperfunctioning, such as certain types cancers. Compounds of formula (1) and methods of preparing the compounds are disclosed in the invention.
    本发明提供了公式(1)的三唑三嗪衍生物作为A2A受体拮抗剂。公式(1)的化合物和包括这些化合物的药物组合物可用于治疗与A2A受体过度功能有关的疾病,如某些类型的癌症。该发明揭示了公式(1)的化合物和制备这些化合物的方法。
  • Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists
    作者:Matthew D. Morin、Ying Wang、Brian T. Jones、Yuto Mifune、Lijing Su、Hexin Shi、Eva Marie Y. Moresco、Hong Zhang、Bruce Beutler、Dale L. Boger
    DOI:10.1021/jacs.8b09223
    日期:2018.10.31
    from treated human THP-1 myeloid cells differentiated along the macrophage line led to the discovery of the diprovocims. Unique to these efforts and of special interest, the screening leads for this new class of activators of an immune response came from a compound library designed to promote cell-surface receptor dimerization. Subsequent comprehensive structure-activity relationship studies improved the
    使用近 100000 种化合物进行的筛选和用于刺激免疫反应的替代功能测定法测量了 TNF-α 从沿巨噬细胞系分化的处理过的人 THP-1 骨髓细胞中的释放,导致发现了双源蛋白。这些努力的独特之处和特别令人感兴趣的是,这类新型免疫反应激活剂的筛选线索来自旨在促进细胞表面受体二聚化的化合物库。随后的综合构效关系研究将效力提高了 800 倍于筛选先导物的效力,提供了 diprovocim-1 和 diprovocim-2。diprovocims 通过用 TLR1(TLR1/TLR2 激动剂)诱导细胞表面 toll 样受体 (TLR)-2 二聚化和活化而起作用,与任何已知的天然或合成 TLR 激动剂没有结构相似性,并且易于制备和合成修饰,并且选定的成员在人类和鼠类系统中都很活跃。最有效的 diprovocim (3, diprovocim-1) 在人 THP-1 细胞中以极低的浓度 (EC50 =
  • Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
    申请人:Boehringer Ingelheim Pharma GmbH & Co. KG
    公开号:US20040209865A1
    公开(公告)日:2004-10-21
    The present invention relates to alkyne compounds of general formula I 1 wherein the groups and residues A, B, W, X, Y, Z, R 1 and R 2 have the meanings given in claim 1 . The invention further relates to pharmaceutical compositions containing at least one alkyne according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.
    本发明涉及一般式I的炔烃化合物 1 其中基团和残基A、B、W、X、Y、Z、R 1 和R 2 具有权利要求中给出的含义。本发明还涉及含有根据本发明至少一种炔烃的药物组合物。鉴于它们的MCH受体拮抗活性,根据本发明的药物组合物适用于治疗代谢紊乱和/或进食紊乱,特别是肥胖症、暴食症、厌食症、过度进食和糖尿病。
  • Design and Synthesis of Potent, Selective Inhibitors of Endothelin-Converting Enzyme
    作者:Eli M. Wallace、John A. Moliterni、Michael A. Moskal、Alan D. Neubert、Nicholas Marcopulos、Lisa B. Stamford、Angelo J. Trapani、Paula Savage、Mary Chou、Arco Y. Jeng
    DOI:10.1021/jm970787c
    日期:1998.4.1
    ECE-1 and NEP with IC50 values of 14 nM and 2 microM, respectively. Similarly, (S)-[[1-[(2-biphenyl-4-ylethyl)carbamoyl]-4-(2-fluorophenyl)but-3- yny l]amino]methyl]phosphonic acid (56), an arylacetylene amino phosphonate amide, had IC50's of 33 nM and 6.5 microM for ECE-1 and NEP, respectively. Slight modification of the aryl moiety was found to have dramatic effects on ECE-1/NEP selectivity. The 2-fluoro
    内皮素-1是迄今为止发现的最有效的肽血管收缩剂。该肽的翻译后加工的最后一步是内皮素转化酶-1(ECE-1)对其前体的转化,该酶是一种金属蛋白酶,与中性内肽酶24.11(NEP)表现出很高的氨基酸序列同一性,尤其是在催化中心。已经制备了一系列有效的和选择性的含芳基乙炔的ECE-1抑制剂。(S,S)-3-环己基-2-[[5-(2,4-二氟苯基)-2-[(膦酰基甲基)氨基]戊-4-炔基]氨基]丙酸(47),芳基乙炔基氨基发现膦酸二肽可抑制ECE-1和NEP,IC50值分别为14 nM和2 microM。类似地,(S)-[[[[[1-[(2-联苯-4-基乙基)氨基甲酰基] -4-(2-氟苯基)丁-3-yny]氨基]甲基]膦酸(56),芳基乙炔氨基膦酸酯酰胺,对ECE-1和NEP的IC50分别为33 nM和6.5 microM。发现芳基部分的轻微修饰对ECE-1 / NEP选择性具有显着影响。2-氟
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐